Cargando…

Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study

BACKGROUND: Uganda’s current guidelines recommend immediate initiation of Anti-Retroviral Therapy (ART) for persons living with HIV in order to reduce HIV/AIDS related morbidity and mortality. However, not all eligible PLHIV initiate ART within the recommended time following HIV diagnosis. We assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiyingi, Micheal, Nankabirwa, Joaniter I., Sekaggya-Wiltshire, Christine, Nangendo, Joan, Kiweewa, John M., Katahoire, Anne R., Semitala, Fred C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843953/
https://www.ncbi.nlm.nih.gov/pubmed/36647104
http://dx.doi.org/10.1186/s12913-023-09052-z
_version_ 1784870514343280640
author Kiyingi, Micheal
Nankabirwa, Joaniter I.
Sekaggya-Wiltshire, Christine
Nangendo, Joan
Kiweewa, John M.
Katahoire, Anne R.
Semitala, Fred C.
author_facet Kiyingi, Micheal
Nankabirwa, Joaniter I.
Sekaggya-Wiltshire, Christine
Nangendo, Joan
Kiweewa, John M.
Katahoire, Anne R.
Semitala, Fred C.
author_sort Kiyingi, Micheal
collection PubMed
description BACKGROUND: Uganda’s current guidelines recommend immediate initiation of Anti-Retroviral Therapy (ART) for persons living with HIV in order to reduce HIV/AIDS related morbidity and mortality. However, not all eligible PLHIV initiate ART within the recommended time following HIV diagnosis. We assessed the prevalence and factors associated with delayed ART initiation among PLHIV referred for ART initiation, five years since rolling out the test and treat guidelines. METHODS: In this cross-sectional study, we enrolled adult patients referred to Mulago Immune Suppressive Syndrome (Mulago ISS) clinic for ART initiation from January 2017 to May 2021. We collected data on socio-demographics, HIV diagnosis and referral circumstances, and time to ART initiation using a questionnaire. The outcome of interest was proportion of patients that delayed ART, defined as spending more than 30 days from HIV diagnosis to ART initiation. We performed multivariable logistic regression and identified significant factors. RESULTS: A total of 312 patients were enrolled of which 62.2% were female. The median (inter-quartile range [IQR]) age and baseline CD4 count of the patients were 35 (28–42) years and 315 (118.8–580.5) cells/μL respectively. Forty-eight (15.4%) patients delayed ART initiation and had a median (IQR) time to ART of 92 (49.0–273.5) days. The factors associated with delayed ART initiation were; 1) having had the HIV diagnosis made from a private health facility versus public, (adjusted odds ratio [aOR] = 2.4 (95% confidence interval [CI] 1.1–5.5); 2) initial denial of positive HIV test results, aOR = 5.4 (95% CI: 2.0–15.0); and, 3) having not received a follow up phone call from the place of HIV diagnosis, aOR = 2.8 (95% CI: 1.2–6.8). CONCLUSION: There was significant delay of ART initiation among referred PLHIV within 5 years after the rollout of test and treat guidelines in Uganda. Health system challenges in the continuity of HIV care services negatively affects timely ART initiation among referred PLHIV in Uganda.
format Online
Article
Text
id pubmed-9843953
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98439532023-01-18 Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study Kiyingi, Micheal Nankabirwa, Joaniter I. Sekaggya-Wiltshire, Christine Nangendo, Joan Kiweewa, John M. Katahoire, Anne R. Semitala, Fred C. BMC Health Serv Res Research BACKGROUND: Uganda’s current guidelines recommend immediate initiation of Anti-Retroviral Therapy (ART) for persons living with HIV in order to reduce HIV/AIDS related morbidity and mortality. However, not all eligible PLHIV initiate ART within the recommended time following HIV diagnosis. We assessed the prevalence and factors associated with delayed ART initiation among PLHIV referred for ART initiation, five years since rolling out the test and treat guidelines. METHODS: In this cross-sectional study, we enrolled adult patients referred to Mulago Immune Suppressive Syndrome (Mulago ISS) clinic for ART initiation from January 2017 to May 2021. We collected data on socio-demographics, HIV diagnosis and referral circumstances, and time to ART initiation using a questionnaire. The outcome of interest was proportion of patients that delayed ART, defined as spending more than 30 days from HIV diagnosis to ART initiation. We performed multivariable logistic regression and identified significant factors. RESULTS: A total of 312 patients were enrolled of which 62.2% were female. The median (inter-quartile range [IQR]) age and baseline CD4 count of the patients were 35 (28–42) years and 315 (118.8–580.5) cells/μL respectively. Forty-eight (15.4%) patients delayed ART initiation and had a median (IQR) time to ART of 92 (49.0–273.5) days. The factors associated with delayed ART initiation were; 1) having had the HIV diagnosis made from a private health facility versus public, (adjusted odds ratio [aOR] = 2.4 (95% confidence interval [CI] 1.1–5.5); 2) initial denial of positive HIV test results, aOR = 5.4 (95% CI: 2.0–15.0); and, 3) having not received a follow up phone call from the place of HIV diagnosis, aOR = 2.8 (95% CI: 1.2–6.8). CONCLUSION: There was significant delay of ART initiation among referred PLHIV within 5 years after the rollout of test and treat guidelines in Uganda. Health system challenges in the continuity of HIV care services negatively affects timely ART initiation among referred PLHIV in Uganda. BioMed Central 2023-01-16 /pmc/articles/PMC9843953/ /pubmed/36647104 http://dx.doi.org/10.1186/s12913-023-09052-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kiyingi, Micheal
Nankabirwa, Joaniter I.
Sekaggya-Wiltshire, Christine
Nangendo, Joan
Kiweewa, John M.
Katahoire, Anne R.
Semitala, Fred C.
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
title Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
title_full Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
title_fullStr Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
title_full_unstemmed Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
title_short Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
title_sort predictors of delayed anti-retroviral therapy initiation among adults referred for hiv treatment in uganda: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843953/
https://www.ncbi.nlm.nih.gov/pubmed/36647104
http://dx.doi.org/10.1186/s12913-023-09052-z
work_keys_str_mv AT kiyingimicheal predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy
AT nankabirwajoaniteri predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy
AT sekaggyawiltshirechristine predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy
AT nangendojoan predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy
AT kiweewajohnm predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy
AT katahoireanner predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy
AT semitalafredc predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy